kareo - is it time to look at new revenue streams?

30
PAGE 1 KAREO | @GoKareo; #KareoTip PAGE 1 Is It Time for New Revenue Streams? KAREO | @GoKareo; #KareoTip

Upload: kareo

Post on 07-May-2015

1.035 views

Category:

Health & Medicine


1 download

DESCRIPTION

Watch recorded webinar: http://www.kareo.com/resources/webinars Are you giving money away to your competitors? If you aren’t considering additional revenue streams for your practice, you might be. Patient expectations are changing and some insurance plans are paying more if you meet new criteria or offer expanded care. In this webinar, Rochelle Glassman will discuss how adding innovative new services can increase revenue while also improving patient care and outcomes. You’ll learn: - When to add a new service and what type of services to consider - How to evaluate your payers and patients to choose the services that will generate the most revenue - How to add services that labs and other vendors may pay you directly for and that will assist in patient clinical management - And, how to train staff, market new services, and work with third-party vendors

TRANSCRIPT

Page 1: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 1 KAREO | @GoKareo; #KareoTip PAGE 1

Is It Time for New Revenue Streams?

KAREO | @GoKareo; #KareoTip

Page 2: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 2 KAREO | @GoKareo; #KareoTip

Our Schedule for Today…

1 Introduction & Welcome Rochelle

2 Is It Time for New Revenue Streams?

3 Discover Kareo’s Role

4 Answer Questions

Page 3: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 3 KAREO | @GoKareo; #KareoTip

Your Hosts…

Rochelle Glassman President, United Physician Services, LLC

.

Lea Chatham Content Marketing Manager, Kareo

Page 4: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 4 KAREO | @GoKareo; #KareoTip

Rochelle Glassman

Nationally-recognized healthcare consultant Former executive-level consultant for Cigna Healthcare business entrepreneur 30 years of healthcare business experience President/CEO United Physician Services,

LLC Physician Advocate

Trauma-trained RN

[email protected]

www.UPSHealthcare.com 602.685.9500

Page 5: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 5 KAREO | @GoKareo; #KareoTip

Participate via Social

Facebook.com/GoKareo

Twitter.com/GoKareo

Linkedin.com/company/Kareo

We’ll be live tweeting during today’s webinar! How to participate: 1. Follow @GoKareo on Twitter 2. Search for #KareoTip 3. Join the conversation using #KareoTip

Page 6: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 6 KAREO | @GoKareo; #KareoTip

Our Schedule for Today…

1 Introduction & Welcome Rochelle

2 Is It Time for New Revenue Streams?

3 Discover Kareo’s Role

4 Answer Questions

Page 7: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 7 KAREO | @GoKareo; #KareoTip

You Can Make More Money

There are new opportunities:

Many preventative services are now covered!

Environment is changing from fee-for-service to pay-for-performance.

New advances in medicine can be added to your practice.

Page 8: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 8 KAREO | @GoKareo; #KareoTip

Pay-for-Performance

Payment is based on metrics

HEDIS

Used by 90% of health plans

Quality measurements

Focuses on preventative care

More ‘whole picture’ approach

Page 9: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 9 KAREO | @GoKareo; #KareoTip

Screening for Diabetic Retinopathy

Leading cause of blindness among diabetics:

25.8 million people in the US have diabetes

79 million have pre-diabetes

28% of diabetic patients have diabetic retinopathy

80% of referrals to obtain eye examinations NEVER OCCUR!

Page 10: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 10 KAREO | @GoKareo; #KareoTip

Screening for Diabetic Retinopathy

In-house optometrist

Increase patient compliance

Improve clinical outcomes

Reimbursement for eye exams AND bonus from health plan!

Page 11: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 11 KAREO | @GoKareo; #KareoTip

Dermatology Care

Most common form of cancer but easily treatable 1 in 5 get skin cancer Bringing in on-site dermatologist Additional revenue Better detection Improved compliance

Joint ventures with MOHs lab

Page 12: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 12 KAREO | @GoKareo; #KareoTip

Drug Testing

Traditionally patients were sent to the lab

Toxicology down to the nanogram

Better to assess in clinical setting

EHR compatible

Reimbursement of about $25 to $30

- Medicaid & Medicare CPT (G0434) - Insurance & Work-Comp CPT (80104)

Page 13: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 13 KAREO | @GoKareo; #KareoTip

Drug Testing

Pain Management

Neurology

Anesthesiology

Surgeons (post operative and pre operative)

Treatment centers

OB/GYN

Internal Medicine

Page 14: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 14 KAREO | @GoKareo; #KareoTip

Depression Research Studies

New, clinically valuable testing strategies

Target depression and appropriate treatment

Historically subjective, now more objective

Lab reimbursement at $75 per patient

Page 15: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 15 KAREO | @GoKareo; #KareoTip

Depression Research Studies

Primary care docs misdiagnose depression 50% of the time

First of class blood test Looks at 9 bio markers across 4

pathways

Score of 1-9 with sensitivity of 94% and specificity of 92% overall accuracy of 93%

Score of 1-4 = 95% likelihood of not having major depressive disorder (MDD)

Score of 5-9 = 90% likelihood of having MDD

Page 16: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 16 KAREO | @GoKareo; #KareoTip

Pharmacogenetic Testing

New system of prescribing according to genetic make-up

More accurate

Better results

Less side effects

Potential marketing

Additional revenue stream

Page 17: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 17 KAREO | @GoKareo; #KareoTip

Pharmacogenetic Testing

100,000+ die each year due to medication-related errors

770,00+ are hospitalized yearly for Adverse Drug Reactions

Prescribe medications through science, not guesswork!

Zero capital costs to the practice

Page 18: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 18 KAREO | @GoKareo; #KareoTip

Pharmacogenetic Testing

Remuneration of either $15 or $75 per patient working

Simple 30 second cheek swab

Reimbursed by all plans except Medicaid

Specialties: primary care, internal medicine, pain management, neurology and psychiatry

Page 19: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 19 KAREO | @GoKareo; #KareoTip

Medical Weight Loss

Covered for up to 26 visits per year (exclusions may apply) for patients with a BMI >30.

1 visit every week for first month

1 visit every other week for 2-6 months

1 visit every month for months 7-17

CPT code G0447

Page 20: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 20 KAREO | @GoKareo; #KareoTip

Medical Weight Loss

Nutritional counseling covered with certain patients with diabetes and renal disease (i.e., CPT code 97802 and 97803)

Partner with specialties to attract patients

Great preventative measure to achieve benchmarks

Happier patients

Page 21: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 21 KAREO | @GoKareo; #KareoTip

Our Schedule for Today…

1 Introduction & Welcome Rochelle

2 Is It Time for New Revenue Streams

3 Discover Kareo’s Role

4 Answer Questions

Page 22: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 22 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

Cloud-based Medical Billing Patient Payment Services Insurance Billing & Remittance Scheduling & Practice Management Electronic Health Records Medical Billing Services Education, Training, & Support Included

20,000 Providers Nationwide

Page 23: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 23 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

Page 24: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 24 KAREO | @GoKareo; #KareoTip

Educational Resources

Kareo.com/meaningful-use

Kareo.com/icd-10

Page 25: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 25 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

•Kareo EHR • In-house labs • In-house

draw/swab and send out lab

Page 26: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 26 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

•Kareo EHR • In-house labs • In-house

draw/swab and send out lab

• Mental health notes and templates

Page 27: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 27 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

•Kareo EHR • In-house labs • In-house

draw/swab and send out lab

• Mental health notes and templates

• Obesity templates

Page 28: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 28 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

•Kareo EHR • In-house labs • In-house

draw/swab and send out lab

• Mental health notes and templates

• Obesity templates • USPSTF

Recommendations

Page 29: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 29 KAREO | @GoKareo; #KareoTip

Discover Kareo’s Role

•Kareo EHR • In-house labs • In-house draw/swab

and send out lab • Mental health notes

and templates • Obesity templates • USPSTF

Recommendations • Kareo PM

• Track HEDIS measures

• Schedule multiple providers/resources

Page 30: Kareo - Is It Time to Look at New Revenue Streams?

PAGE 30 KAREO | @GoKareo; #KareoTip

Let’s Answer Your Questions

866-231-2871 [email protected] Kareo.com/chat

Facebook.com/GoKareo

Twitter.com/GoKareo

Linkedin.com/company/Kareo

Follow us!